J&J opts out of new wellness unit

All's well that ends well? Johnson & Johnson has decided not to launch a stand-alone wellness and disease-prevention unit. Instead, it's planning to expand its business in that area under the umbrella of its consumer unit. Last year, J&J announced its wellness intentions with the acquisition of HealthMedia, saying that it hoped the new unit would account for $20 billion in revenue. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.